From the Centers for Disease Control and Prevention. Sudden death in a traveler following halofantrine administration--Togo, 2000.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000962:Antimalarials / Q000009:adverse effects*; D006332:Cardiomegaly / Q000150:complications*; D003645:Death, Sudden / Q000209:etiology*; D004347:Drug Interactions; D004917:Erythromycin / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D018942:Macrolides; D008297:Male; D015767:Mefloquine / Q000627:therapeutic use; D010616:Phenanthrenes / Q000009:adverse effects*; D014037:Togo; D014195:Travel
D000900:Anti-Bacterial Agents; D000962:Antimalarials; D018942:Macrolides; D010616:Phenanthrenes; C053853:dirithromycin; D004917:Erythromycin; C023768:halofantrine; D015767:Mefloquine